Skip to main content

Published locations for Priming tremelimumab dose regimen shows promising benefit-risk profile in HCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Priming tremelimumab dose regimen shows promising benefit-risk profile in HCC

User login

  • Reset your password
  • /content/priming-tremelimumab-dose-regimen-shows-promising-benefit-risk-profile-hcc
  • /gihepnews/article/247564/gastrointestinal-cancer/priming-tremelimumab-dose-regimen-shows-promising
  • /internalmedicinenews/article/247564/gastrointestinal-cancer/priming-tremelimumab-dose-regimen-shows
  • /oncologypractice/article/247564/gastrointestinal-cancer/priming-tremelimumab-dose-regimen-shows
  • /hematology-oncology/article/247564/gastrointestinal-cancer/priming-tremelimumab-dose-regimen-shows
  • /internalmedicine/article/247564/gastrointestinal-cancer/priming-tremelimumab-dose-regimen-shows